Skip to main content

Table 1 Statistical tests

From: The effect of small-molecule inhibition of MAPKAPK2 on cell ageing phenotypes of fibroblasts from human Werner syndrome

Treatment

NDFsa

WSa

NDFs / WSb

MK2.III (5μM)

p > 0.37

p < 0.05

p < 0.029

SB203580 (2.5μM)

p < 0.05

p < 0.036

p < 0.014

  1. a Probability that inhibitor treatment results in no significant extension of replicative capacity for NDFs or WS fibroblasts compared to DMSO-treated cells (paired t-test).
  2. b Probability that the extension of replicative capacity seen for WS cells is not greater than that seen for NDFs for same treatment (unpaired 2-tailed t-test).